Cargando…

PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia

Intratumoral accumulation of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells occurs in acute myeloid leukemia (AML), but little is known about the role of tumor cells themselves in this process. Here, we showed that an immune checkpoint PD-L1 expressed by AML cells promoted the conversion and expans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yuqing, Han, Yixiang, Huang, Yisha, Jiang, Songfu, Huang, Ziyang, Chen, Rongrong, Yu, Zhijie, Yu, Kang, Zhang, Shenghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412746/ https://www.ncbi.nlm.nih.gov/pubmed/32849603 http://dx.doi.org/10.3389/fimmu.2020.01710

Ejemplares similares

Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells
por: Han, Yixiang, et al.
Publicado: (2018)

Casein kinase 1α inhibits p53 downstream of MDM2-mediated autophagy and apoptosis in acute myeloid leukemia
por: Xu, Wanling, et al.
Publicado: (2020)

Matrine induces Akt/mTOR signalling inhibition‐mediated autophagy and apoptosis in acute myeloid leukaemia cells
por: Wu, Junqing, et al.
Publicado: (2016)

Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia
por: Zhang, Qianying, et al.
Publicado: (2021)

Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia
por: Huang, Ziyang, et al.
Publicado: (2023)

Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia
por: Zhang, Qianying, et al.
Publicado: (2017)

Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin
por: Han, Yixiang, et al.
Publicado: (2015)

MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia
por: Li, Fanfan, et al.
Publicado: (2023)

Increase of CD3(+)CD7(−) T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin’s lymphoma
por: Huang, Ziyang, et al.
Publicado: (2022)

Progress of research on PD-1/PD-L1 in leukemia
por: Cao, Huizhen, et al.
Publicado: (2023)

Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
por: Han, Yixiang, et al.
Publicado: (2014)

Benzene induces haematotoxicity by promoting deacetylation and autophagy
por: Qian, Shanhu, et al.
Publicado: (2018)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

CD26(low)PD-1(+) CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia
por: Zhou, Huarong, et al.
Publicado: (2023)

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
por: Yang, Xingcheng, et al.
Publicado: (2022)

Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
por: Jiang, Siqing, et al.
Publicado: (2022)

The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8(+) T Cells During an Acute Retroviral Infection
por: David, Paul, et al.
Publicado: (2019)

A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia
por: Zhu, Kai, et al.
Publicado: (2022)

Matrine Induces Apoptosis in Human Acute Myeloid Leukemia Cells via the Mitochondrial Pathway and Akt Inactivation
por: Zhang, Shenghui, et al.
Publicado: (2012)

Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
por: del Rio, Maria-Luisa, et al.
Publicado: (2022)

Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?
por: Jimbu, Laura, et al.
Publicado: (2021)

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
por: Jimenez, Rachel V., et al.
Publicado: (2019)

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice
por: Chen, Yu, et al.
Publicado: (2020)

Role of regulation of PD-1 and PD-L1 expression in sepsis
por: Zhang, Teng, et al.
Publicado: (2023)

Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia
por: Kubicka, Ewa, et al.
Publicado: (2022)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia
por: Li, Zhongzheng, et al.
Publicado: (2023)

Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis
por: Ruan, Wei-Shuyi, et al.
Publicado: (2020)

Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia
por: Liang, Haoyue, et al.
Publicado: (2023)

Cancer-Associated Myeloid Regulatory Cells
por: De Vlaeminck, Yannick, et al.
Publicado: (2016)

Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout
por: Zhong, Limei, et al.
Publicado: (2020)

The cytokine network in acute myeloid leukemia
por: Luciano, Michela, et al.
Publicado: (2022)

Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia
por: Huang, Yueting, et al.
Publicado: (2023)

Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer
por: Ma, Yangyang, et al.
Publicado: (2023)

STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
por: Huang, Ze-Wei, et al.
Publicado: (2023)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
por: Qiao, Xin-wei, et al.
Publicado: (2020)

Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells
por: Huang, Wei, et al.
Publicado: (2021)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy
por: Liu, Junjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_09tssh83tjsn4oorig3k884881